Literature DB >> 19015348

Targeting type III secretion in Yersinia pestis.

Ning J Pan1, Michael J Brady, John M Leong, Jon D Goguen.   

Abstract

Yersinia pestis, the causative agent of plague, utilizes a plasmid-encoded type III secretion system (T3SS) to aid it with its resistance to host defenses. This system injects a set of effector proteins known as Yops (Yersinia outer proteins) into the cytosol of host cells that come into contact with the bacteria. T3SS is absolutely required for the virulence of Y. pestis, making it a potential target for new therapeutics. Using a novel and simple high-throughput screening method, we examined a diverse collection of chemical libraries for small molecules that inhibit type III secretion in Y. pestis. The primary screening of 70,966 compounds and mixtures yielded 421 presumptive inhibitors. We selected eight of these for further analysis in secondary assays. Four of the eight compounds effectively inhibited Yop secretion at micromolar concentrations. Interestingly, we observed differential inhibition among Yop species with some compounds. The compounds did not inhibit bacterial growth at the concentrations used in the inhibition assays. Three compounds protected HeLa cells from type III secretion-dependent cytotoxicity. Of the eight compounds examined in secondary assays, four show good promise as leads for structure-activity relationship studies. They are a diverse group, with each having a chemical scaffold not only distinct from each other but also distinct from previously described candidate type III secretion inhibitors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19015348      PMCID: PMC2630656          DOI: 10.1128/AAC.00670-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

1.  [Development of the screening system for the bacterial type III secretion apparatus inhibitor].

Authors:  Akio Abe
Journal:  Jpn J Antibiot       Date:  2002-06

Review 2.  The Yersinia Ysc-Yop 'type III' weaponry.

Authors:  Guy R Cornelis
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

3.  Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle.

Authors:  Leslie Bailey; Asa Gylfe; Charlotta Sundin; Sandra Muschiol; Mikael Elofsson; Peter Nordström; Birgitta Henriques-Normark; Raimond Lugert; Anders Waldenström; Hans Wolf-Watz; Sven Bergström
Journal:  FEBS Lett       Date:  2007-01-17       Impact factor: 4.124

4.  Status of YopM and YopN in the Yersinia Yop virulon: YopM of Y.enterocolitica is internalized inside the cytosol of PU5-1.8 macrophages by the YopB, D, N delivery apparatus.

Authors:  A Boland; M P Sory; M Iriarte; C Kerbourch; P Wattiau; G R Cornelis
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

5.  Targeting bacterial virulence: inhibitors of type III secretion in Yersinia.

Authors:  Anna M Kauppi; Roland Nordfelth; Hanna Uvell; Hans Wolf-Watz; Mikael Elofsson
Journal:  Chem Biol       Date:  2003-03

6.  Essential virulence determinants of different Yersinia species are carried on a common plasmid.

Authors:  R Ben-Gurion; A Shafferman
Journal:  Plasmid       Date:  1981-03       Impact factor: 3.466

7.  Caminoside A, an antimicrobial glycolipid isolated from the marine sponge Caminus sphaeroconia.

Authors:  Roger G Linington; Marilyn Robertson; Annick Gauthier; B Brett Finlay; Rob van Soest; Raymond J Andersen
Journal:  Org Lett       Date:  2002-11-14       Impact factor: 6.005

8.  Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells.

Authors:  M P Sory; G R Cornelis
Journal:  Mol Microbiol       Date:  1994-11       Impact factor: 3.501

9.  Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar typhimurium.

Authors:  Aurel Negrea; Eva Bjur; Sofia Eriksson Ygberg; Mikael Elofsson; Hans Wolf-Watz; Mikael Rhen
Journal:  Antimicrob Agents Chemother       Date:  2007-06-04       Impact factor: 5.191

10.  Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli.

Authors:  Kenan C Murphy; Kenneth G Campellone
Journal:  BMC Mol Biol       Date:  2003-12-13       Impact factor: 2.946

View more
  31 in total

1.  Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion.

Authors:  Daniel Aiello; John D Williams; Helena Majgier-Baranowska; Ishan Patel; Norton P Peet; Jin Huang; Stephen Lory; Terry L Bowlin; Donald T Moir
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

2.  A multi-pronged search for a common structural motif in the secretion signal of Salmonella enterica serovar Typhimurium type III effector proteins.

Authors:  Garry W Buchko; George Niemann; Erin S Baker; Mikhail E Belov; Richard D Smith; Fred Heffron; Joshua N Adkins; Jason E McDermott
Journal:  Mol Biosyst       Date:  2010-09-29

3.  A type III secretion system inhibitor targets YopD while revealing differential regulation of secretion in calcium-blind mutants of Yersinia pestis.

Authors:  Danielle L Jessen; David S Bradley; Matthew L Nilles
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

Review 4.  Chemical inhibitors of the type three secretion system: disarming bacterial pathogens.

Authors:  Miles C Duncan; Roger G Linington; Victoria Auerbuch
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

5.  The bacterial type III secretion system as a target for developing new antibiotics.

Authors:  Andrew C McShan; Roberto N De Guzman
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

6.  Chemical Targeting and Manipulation of Type III Secretion in the Phytopathogen Xanthomonas campestris for Control of Disease.

Authors:  Le Zhou; Cheng Wang; Guo-Hua Wang; Zai-Wa Wei; Qiu-Xia Fu; Xiao-Hong Hang; Mei Yang; Bo-Le Jiang; Ji-Liang Tang
Journal:  Appl Environ Microbiol       Date:  2020-01-21       Impact factor: 4.792

7.  Alveolar macrophages and neutrophils are the primary reservoirs for Legionella pneumophila and mediate cytosolic surveillance of type IV secretion.

Authors:  Alan M Copenhaver; Cierra N Casson; Hieu T Nguyen; Thomas C Fung; Matthew M Duda; Craig R Roy; Sunny Shin
Journal:  Infect Immun       Date:  2014-08-04       Impact factor: 3.441

8.  Cytosporone B, an inhibitor of the type III secretion system of Salmonella enterica serovar Typhimurium.

Authors:  Jianfang Li; Chao Lv; Weiyang Sun; Zhenyu Li; Xiaowei Han; Yaoyao Li; Yuemao Shen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

9.  An NF-κB-based high-throughput screen identifies piericidins as inhibitors of the Yersinia pseudotuberculosis type III secretion system.

Authors:  Miles C Duncan; Weng Ruh Wong; Allison J Dupzyk; Walter M Bray; Roger G Linington; Victoria Auerbuch
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

10.  N-hydroxybenzimidazole inhibitors of the transcription factor LcrF in Yersinia: novel antivirulence agents.

Authors:  Oak K Kim; Lynne K Garrity-Ryan; Victoria J Bartlett; Mark C Grier; Atul K Verma; Gabriel Medjanis; Janice E Donatelli; Ann B Macone; S Ken Tanaka; Stuart B Levy; Michael N Alekshun
Journal:  J Med Chem       Date:  2009-09-24       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.